BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 11600590)

  • 1. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans.
    Broglio F; Arvat E; Benso A; Gottero C; Muccioli G; Papotti M; van der Lely AJ; Deghenghi R; Ghigo E
    J Clin Endocrinol Metab; 2001 Oct; 86(10):5083-6. PubMed ID: 11600590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone.
    Arvat E; Maccario M; Di Vito L; Broglio F; Benso A; Gottero C; Papotti M; Muccioli G; Dieguez C; Casanueva FF; Deghenghi R; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1169-74. PubMed ID: 11238504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetylcholine does not play a major role in mediating the endocrine responses to ghrelin, a natural ligand of the GH secretagogue receptor, in humans.
    Broglio F; Gottero C; Benso A; Prodam F; Casanueva FF; Dieguez C; van der Lely AJ; Deghenghi R; Arvat E; Ghigo E
    Clin Endocrinol (Oxf); 2003 Jan; 58(1):92-8. PubMed ID: 12519418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-acylated ghrelin does not possess the pituitaric and pancreatic endocrine activity of acylated ghrelin in humans.
    Broglio F; Benso A; Gottero C; Prodam F; Gauna C; Filtri L; Arvat E; van der Lely AJ; Deghenghi R; Ghigo E
    J Endocrinol Invest; 2003 Mar; 26(3):192-6. PubMed ID: 12809167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state.
    Broglio F; Gianotti L; Destefanis S; Fassino S; Abbate Daga G; Mondelli V; Lanfranco F; Gottero C; Gauna C; Hofland L; Van der Lely AJ; Ghigo E
    Clin Endocrinol (Oxf); 2004 May; 60(5):592-9. PubMed ID: 15104562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans.
    Broglio F; Gottero C; Prodam F; Gauna C; Muccioli G; Papotti M; Abribat T; Van Der Lely AJ; Ghigo E
    J Clin Endocrinol Metab; 2004 Jun; 89(6):3062-5. PubMed ID: 15181099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The GH-releasing effect of ghrelin, a natural GH secretagogue, is only blunted by the infusion of exogenous somatostatin in humans.
    Di Vito L; Broglio F; Benso A; Gottero C; Prodam F; Papotti M; Muccioli G; Dieguez C; Casanueva FF; Deghenghi R; Ghigo E; Arvat E
    Clin Endocrinol (Oxf); 2002 May; 56(5):643-8. PubMed ID: 12030916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of glucose, free fatty acids or arginine load on the GH-releasing activity of ghrelin in humans.
    Broglio F; Benso A; Gottero C; Prodam F; Grottoli S; Tassone F; Maccario M; Casanueva FF; Dieguez C; Deghenghi R; Ghigo E; Arvat E
    Clin Endocrinol (Oxf); 2002 Aug; 57(2):265-71. PubMed ID: 12153607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrine responses to ghrelin in adult patients with isolated childhood-onset growth hormone deficiency.
    Aimaretti G; Baffoni C; Broglio F; Janssen JA; Corneli G; Deghenghi R; van der Lely AJ; Ghigo E; Arvat E
    Clin Endocrinol (Oxf); 2002 Jun; 56(6):765-71. PubMed ID: 12072046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary evidence that Ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans.
    Arvat E; Di Vito L; Broglio F; Papotti M; Muccioli G; Dieguez C; Casanueva FF; Deghenghi R; Camanni F; Ghigo E
    J Endocrinol Invest; 2000 Sep; 23(8):493-5. PubMed ID: 11021763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortistatin-17 and -14 exert the same endocrine activities as somatostatin in humans.
    Gottero C; Prodam F; Destefanis S; Benso A; Gauna C; Me E; Filtri L; Riganti F; Van Der Lely AJ; Ghigo E; Broglio F
    Growth Horm IGF Res; 2004 Oct; 14(5):382-7. PubMed ID: 15336231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabolic response to the activation of the beta-adrenergic receptor by salbutamol is amplified by acylated ghrelin.
    St-Pierre DH; Benso A; Gramaglia E; Prodam F; Lucatello B; Ramella-Gigliardi V; Olivetti I; Tomelini M; Broglio F
    J Endocrinol Invest; 2010 Jun; 33(6):363-7. PubMed ID: 20631491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of recombinant human insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH-releasing hormone or hexarelin, a peptidyl GH secretagogue, in humans.
    Ghigo E; Gianotti L; Arvat E; Ramunni J; Valetto MR; Broglio F; Rolla M; Cavagnini F; Müller EE
    J Clin Endocrinol Metab; 1999 Jan; 84(1):285-90. PubMed ID: 9920097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. d-Lys-GHRP-6 does not modify the endocrine response to acylated ghrelin or hexarelin in humans.
    Benso A; Prodam F; Lucatello B; Gramaglia E; Riganti F; Schneider H; van der Lely AJ; Muccioli G; Ghigo E; Broglio F
    Neuropeptides; 2007 Feb; 41(1):45-9. PubMed ID: 17112585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ghrelin secretion is inhibited by either somatostatin or cortistatin in humans.
    Broglio F; Koetsveld Pv Pv; Benso A; Gottero C; Prodam F; Papotti M; Muccioli G; Gauna C; Hofland L; Deghenghi R; Arvat E; Van Der Lely AJ; Ghigo E
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4829-32. PubMed ID: 12364482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine activities of cortistatin-14 and its interaction with GHRH and ghrelin in humans.
    Broglio F; Arvat E; Benso A; Gottero C; Prodam F; Grottoli S; Papotti M; Muccioli G; van der Lely AJ; Deghenghi R; Ghigo E
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3783-90. PubMed ID: 12161511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the combined administration of hexarelin, a synthetic peptidyl GH secretagogue, and hCRH on ACTH, cortisol and GH secretion in patients with Cushing's disease.
    Arvat E; Ramunni J; Giordano R; Maccagno B; Broglio F; Benso A; Deghenghi R; Ghigo E
    J Endocrinol Invest; 1999 Jan; 22(1):23-8. PubMed ID: 10090133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lowered ghrelin levels in acromegaly—normalization after treatment].
    Kozakowski J; Rabijewski M; Zgliczyński W
    Endokrynol Pol; 2005; 56(6):862-70. PubMed ID: 16821203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ghrelin does not mediate the somatotroph and corticotroph responses to the stimulatory effect of glucagon or insulin-induced hypoglycaemia in humans.
    Broglio F; Prodam F; Gottero C; Destefanis S; Me E; Riganti F; Giordano R; Picu A; Balbo M; Van der Lely AJ; Ghigo E; Arvat E
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):699-704. PubMed ID: 15163333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between glucagon and hexarelin, a peptidyl GH secretagogue, on somatotroph and corticotroph secretion in humans.
    Arvat E; Maccagno B; Ramunni J; Giordano R; Broglio F; Gianotti L; Maccario M; Camanni F; Ghigo E
    Eur J Endocrinol; 2000 Nov; 143(5):601-6. PubMed ID: 11078983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.